All stories tagged :

Sample Category Title

AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across...

admin
People

France Social Commerce Market Databook 2025: Competitive Landscape and Regulatory Developments...

admin
Pr Newswire

Celldex Presents Unprecedented 76 Week Results from Barzolvolimab Phase 2 Study...

admin
Pr Newswire

Daré Bioscience Announces Adjournment of Annual Meeting of Stockholders

admin
Pr Newswire

Hapbee Is Upgrading U.S. Listing to OTCID to Expand Investor Access...

admin
Pr Newswire

DBV Technologies to Participate in Upcoming EAACI Congress 2025

admin
Pr Newswire

FibroGen Announces 1-for-25 Reverse Stock Split

admin
People

COOFANDY Announces Collaboration with Luxury Designer Matteo Menotto to Advance Global...

admin
People

Toronto Downtown West BIA launches 2025 ultimate summer guide

admin
People

Clean Energy Firms Risk Falling Behind: Scoop Brings Field Service Management...

admin
People

Sunrise Maids Gives Back to Katy TX with More Than Just...

admin

Featured

Pr Newswire

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

admin
Pr Newswire

Virtual IT Group and The Instillery Go to Town on Zero...

admin
Pr Newswire

HKUST Deepens Sweden Ties Positioning Hong Kong as a Strategic Nexus...

admin
Pr Newswire

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for...

admin
admin

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

7 new NEFECON® real-world evidence abstracts will be presented at the 18th International lgA Nephropathy Symposium (IIgANN 2025). The newly released results, based on clinical practices at several leading hospitals in China, offer a comprehensive overview of the efficacy and safety of NEFECON® in the treatment of IgA...